X0508 4 2025-01-16 false 0001597553 Sage Therapeutics, Inc. SAGE 0001881403 Benecchi Christopher C/O SAGE THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 false true false false Chief Operating Officer false Common Stock 2025-01-16 4 A false 20000.00 0.00 A 44737.00 D Stock Options (Right to buy) 6.97 2025-01-16 4 A false 40000.00 0.00 A 2035-01-16 Common Stock 40000.00 40000.00 D Consists of shares of common stock issuable under 20,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026. The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 10,000 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 30,000 shares vesting in 36 equal monthly installments thereafter. Brandon Marsh, attorney in fact for Christopher Benecchi 2025-01-21